- Report
- August 2023
- 336 Pages
Global
From €2544EUR$2,750USD£2,123GBP
€5087EUR$5,500USD£4,245GBP
- Report
- May 2023
- 240 Pages
Global
From €2544EUR$2,750USD£2,123GBP
€5087EUR$5,500USD£4,245GBP
- Report
- March 2022
- 273 Pages
Global
From €2428EUR$2,625USD£2,026GBP
€4856EUR$5,250USD£4,052GBP
- Report
- December 2021
- 296 Pages
Global
From €2428EUR$2,625USD£2,026GBP
€4856EUR$5,250USD£4,052GBP
- Report
- January 2023
- 103 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- November 2022
- 54 Pages
Global
- Report
- September 2022
- 94 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- September 2022
- 62 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- June 2021
- 77 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- August 2025
- 120 Pages
Global
From €5503EUR$5,950USD£4,593GBP
- Report
- February 2025
- 110 Pages
Global
From €5503EUR$5,950USD£4,593GBP
- Report
- May 2025
- 219 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- March 2024
- 163 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- November 2023
- 77 Pages
France
From €3237EUR$3,500USD£2,702GBP
- Report
- October 2025
- 120 Pages
Global
From €5503EUR$5,950USD£4,593GBP
From €3237EUR$3,500USD£2,702GBP
- Report
- September 2024
- 82 Pages
Japan
From €3237EUR$3,500USD£2,702GBP
- Report
- September 2025
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- August 2025
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- June 2025
- 182 Pages
Global
From €4162EUR$4,500USD£3,473GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more